Xuefen Xie

1.2k citations
9 papers · 1.0k indexed · h-index 8
Topics
Cholesterol and Lipid Metabolism (4 papers)Liver Disease Diagnosis and Treatment (4 papers)Peroxisome Proliferator-Activated Receptors (2 papers)

In The Last Decade

Xuefen Xie

9 papers receiving 1.0k citations

Peers

Xuefen Xie
Comparison fields: 5 of 77
  • Physiology 360
  • Molecular Biology 351
  • Endocrine and Autonomic Systems 308
  • Surgery 256
  • Epidemiology 231
Replace Il Seong Nam‐Goong with:
Il Seong Nam‐Goong South Korea
Sidath Katugampola United Kingdom
Mary Jane Zarnowski United States
Krisztina Hegyi Hungary
Kenneth R. McGaffin United States
S Mori Japan
Michio Noguchi Japan
Naja Zenius Jespersen Denmark
María Luisa Villanueva‐Peñacarrillo Spain
An‐Jing Ren China
Xuefen Xie relative to Il Seong Nam‐Goong South Korea Il Seong Nam‐Goong's profile →
Citations per field
00.5×1.5×1.9×
Il Seong Nam‐Goong · 1×
Citations per year

Countries citing papers authored by Xuefen Xie

Since Specialization
Citations

This map shows the geographic impact of Xuefen Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefen Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefen Xie more than expected).

Fields of papers citing papers by Xuefen Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefen Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefen Xie. The network helps show where Xuefen Xie may publish in the future.

Co-authorship network of co-authors of Xuefen Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefen Xie. A scholar is included among the top collaborators of Xuefen Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefen Xie. Xuefen Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 53
2 264
3 9
4 44
5 358
6 81
7 122
8 103
9 2

About Xuefen Xie

Xuefen Xie is a scholar working on Endocrine and Autonomic Systems, Epidemiology and Biochemistry, having authored 9 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (308 citations), Physiology (360 citations) and Nutrition and Dietetics (212 citations). Xuefen Xie has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Guosheng Liang, Joseph L. Goldstein, Michael S. Brown, Yi Zhu, Andrew Murphy, George D. Yancopoulos, Tong‐Jin Zhao, David M. Valenzuela, Mark W. Sleeman and Maria Frank-Kamenetsky. Their work appears in journals such as Proceedings of the National Academy of Sciences, Hepatology and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026